The choice between brand-name and compounded GLP-1 medications is ultimately a personal one that should be made in consultation with your healthcare provider, considering your medical needs, financial situation, risk tolerance, and preferences
Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician
In a separate container, take a half-ounce of your favorite cosmetic or copper-peptide product such as Skin Signals Cream , Regular CP Serum , or TriReduction Cream
doi: 10.1111/dme.14780 33 TranSRetnakaranRZinmanBKramerCK
Glycemic control was slightly better with lixisenatide: mean postbaseline difference, -0.27% (95% CI: -0.32 to -0.22)